Suppr超能文献

发现并鉴定一种泛β冠状病毒 S2 结合抗体。

Discovery and characterization of a pan-betacoronavirus S2-binding antibody.

机构信息

Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 73232, USA.

出版信息

Structure. 2024 Nov 7;32(11):1893-1909.e11. doi: 10.1016/j.str.2024.08.022. Epub 2024 Sep 25.

Abstract

The continued emergence of deadly human coronaviruses from animal reservoirs highlights the need for pan-coronavirus interventions for effective pandemic preparedness. Here, using linking B cell receptor to antigen specificity through sequencing (LIBRA-seq), we report a panel of 50 coronavirus antibodies isolated from human B cells. Of these, 54043-5 was shown to bind the S2 subunit of spike proteins from alpha-, beta-, and deltacoronaviruses. A cryoelectron microscopy (cryo-EM) structure of 54043-5 bound to the prefusion S2 subunit of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike defined an epitope at the apex of S2 that is highly conserved among betacoronaviruses. Although non-neutralizing, 54043-5 induced Fc-dependent antiviral responses in vitro, including antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). In murine SARS-CoV-2 challenge studies, protection against disease was observed after introduction of Leu234Ala, Leu235Ala, and Pro329Gly (LALA-PG) substitutions in the Fc region of 54043-5. Together, these data provide new insights into the protective mechanisms of non-neutralizing antibodies and define a broadly conserved epitope within the S2 subunit.

摘要

从动物宿主中持续出现致命的人类冠状病毒,突出表明需要进行泛冠状病毒干预,以做好有效的大流行病防范。在这里,我们使用通过测序将 B 细胞受体与抗原特异性连接的方法(LIBRA-seq),从人类 B 细胞中分离出了一组 50 种冠状病毒抗体。其中,54043-5 被证明可以结合来自甲型、乙型和丙型冠状病毒的刺突蛋白的 S2 亚基。与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突的预融合 S2 亚基结合的 54043-5 的低温电子显微镜(cryo-EM)结构定义了一个位于 S2 顶点的表位,该表位在乙型冠状病毒中高度保守。尽管 54043-5 不具有中和作用,但它在体外诱导了 Fc 依赖性抗病毒反应,包括抗体依赖性细胞毒性(ADCC)和抗体依赖性细胞吞噬作用(ADCP)。在 SARS-CoV-2 感染的小鼠挑战研究中,在 54043-5 的 Fc 区域引入 Leu234Ala、Leu235Ala 和 Pro329Gly(LALA-PG)取代后,观察到了对疾病的保护。这些数据共同为非中和抗体的保护机制提供了新的见解,并定义了 S2 亚基内的一个广泛保守的表位。

相似文献

1
Discovery and characterization of a pan-betacoronavirus S2-binding antibody.
Structure. 2024 Nov 7;32(11):1893-1909.e11. doi: 10.1016/j.str.2024.08.022. Epub 2024 Sep 25.
2
Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody.
bioRxiv. 2024 Jan 16:2024.01.15.575741. doi: 10.1101/2024.01.15.575741.
3
Allostery Links hACE2 Binding, Pan-variant Neutralization and Helical Extension in the SARS-CoV-2 Spike Protein.
J Mol Biol. 2025 Sep 1;437(17):169232. doi: 10.1016/j.jmb.2025.169232. Epub 2025 May 28.
4
Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies.
J Virol. 2025 Jun 17;99(6):e0055025. doi: 10.1128/jvi.00550-25. Epub 2025 May 19.
6
8
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Structure. 2024 Oct 3;32(10):1594-1602.e6. doi: 10.1016/j.str.2024.07.020. Epub 2024 Aug 21.

引用本文的文献

1
Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus.
Vaccines (Basel). 2025 Jul 17;13(7):761. doi: 10.3390/vaccines13070761.
2
Unveiling the structural spectrum of SARS-CoV-2 fusion by in situ cryo-ET.
Nat Commun. 2025 Jun 3;16(1):5150. doi: 10.1038/s41467-025-60406-z.
3
Unveiling the Complete Spectrum of SARS-CoV-2 Fusion Stages by In Situ Cryo-ET.
bioRxiv. 2025 Feb 27:2025.02.25.640151. doi: 10.1101/2025.02.25.640151.
4
Structural Immunology of SARS-CoV-2.
Immunol Rev. 2025 Jan;329(1):e13431. doi: 10.1111/imr.13431. Epub 2024 Dec 27.
5
Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approaches.
Emerg Microbes Infect. 2025 Dec;14(1):2432345. doi: 10.1080/22221751.2024.2432345. Epub 2024 Dec 9.

本文引用的文献

1
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines.
Nat Commun. 2024 Jun 28;15(1):5496. doi: 10.1038/s41467-024-49656-5.
2
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge.
Nat Commun. 2024 Feb 20;15(1):1553. doi: 10.1038/s41467-024-45404-x.
3
UCSF ChimeraX: Tools for structure building and analysis.
Protein Sci. 2023 Nov;32(11):e4792. doi: 10.1002/pro.4792.
5
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease.
Immunity. 2023 Mar 14;56(3):669-686.e7. doi: 10.1016/j.immuni.2023.02.005. Epub 2023 Feb 16.
7
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses.
EBioMedicine. 2022 Dec;86:104341. doi: 10.1016/j.ebiom.2022.104341. Epub 2022 Nov 11.
8
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein.
Cell Res. 2022 Dec;32(12):1068-1085. doi: 10.1038/s41422-022-00746-3. Epub 2022 Nov 10.
9
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses.
Cell Host Microbe. 2023 Jan 11;31(1):97-111.e12. doi: 10.1016/j.chom.2022.10.010. Epub 2022 Nov 7.
10
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies.
Nat Rev Microbiol. 2023 Feb;21(2):112-124. doi: 10.1038/s41579-022-00809-7. Epub 2022 Oct 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验